Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Eucrisa™ (crisaborole) – New Drug Approval
December 14, 2016 –The FDA announced the approval of Pfizer’s Eucrisa (crisaborole) ointment, for topical treatment of mild to moderate atopic dermatitis (AD) in patients 2 years of age and older.
